Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Helison R. do Carmo"'
Autor:
Andrei C. Sposito, Ikaro Breder, Joaquim Barreto, Jessica Breder, Isabella Bonilha, Marcus Lima, Alessandra Oliveira, Vaneza Wolf, Beatriz Luchiari, Helison R. do Carmo, Daniel Munhoz, Daniela Oliveira, Otavio R. Coelho-Filho, Otavio R. Coelho, Jose Roberto Matos-Souza, Filipe A. Moura, Luiz Sergio F. de Carvalho, Wilson Nadruz, Thiago Quinaglia, Sheila T. Kimura-Medorima, the EXCEED-BHS3 Group
Publikováno v:
Cardiovascular Diabetology, Vol 21, Iss 1, Pp 1-12 (2022)
Abstract Background Sodium-glucose cotransporter 2 inhibitors (SGLT2i) improve endothelial dysfunction and reduce cardiovascular events in individuals with type 2 diabetes (T2D). Proprotein convertase subtilisin/kexin 9 (PCSK9i) inhibitors reduce car
Externí odkaz:
https://doaj.org/article/ed5c4e43a6ac4e2e9cdd979f48b53042
Autor:
Ikaro Breder, Jessica Cunha Breder, Isabella Bonilha, Daniel B. Munhoz, Sheila T. Kimura Medorima, Daniela C. Oliveira, Helison R. do Carmo, Camila Moreira, Anatol Kontush, Francesca Zimetti, Ilaria Zanotti, Luiz Sergio F. Carvalho, Wilson Nadruz, Elza Muscelli, Thiago Quinaglia, Andrei C. Sposito
Publikováno v:
Therapeutic Advances in Chronic Disease, Vol 11 (2020)
Background: Patients with type 2 diabetes mellitus (T2DM) remain at increased cardiovascular residual risk and endothelial dysfunction, even after optimizing metabolic control and treatment by sodium-glucose-2 transporter inhibitors (SGLT2-is). The p
Externí odkaz:
https://doaj.org/article/8b82e83ea8a6454da9dfc7ff7495ff38